Support our Foundation of Myology project
1722 news items
German recommendations for the diagnosis of hereditary or acquired neuropathies in pediatrics
On 28/10/2021
The heterogeneity of the etiologies to be sought is so wide that the diagnosis of neuropathy in a child or adolescent is not always easy.…
CMD linked to LAMA2 deficiency: a pattern of specific muscle damage emerges on MRI
On 27/10/2021
An Egyptian team performed a retrospective study of whole body MRI in 10 children with LAMA2 deficiency, an average of 10.3 years old (+/- 2.8…
A machine learning module for the diagnosis of FSH
On 26/10/2021
The muscle involvement encountered in facio-scapulo-humeral myopathy (FSH) is sometimes confusing for the clinician because of its high selectivity and its often asymmetric nature. Italian…
HAS opinion for Evrysdi® (risdiplam)
On 26/10/2021
The opinion of the Transparency Committee concerning the reimbursement of Evrysdi® (or risdiplam) has just been published. In SMA type I, II and III, Evrysdi®…
ManNAc in GNE myopathy: new positive results
On 25/10/2021
A first phase I clinical trial of ManNAc (a precursor of sialic acid) in 22 people with GNE myopathy followed for 8 months, showed the…
Reducing oxidative stress confines the development of symptoms in GDAP1-related CMT in mice
On 25/10/2021
The GDAP1 gene is involved in several forms of CMT (including CMT 2K and CMT 4A). It encodes a mitochondrial protein. After screening in vitro…
Next-generation pacemaker successfully implanted in an adult with DMD
On 25/10/2021
Heart complications are part of the natural history of Duchenne muscular dystrophy (DMD), especially in adulthood, where they are responsible for a significant number of…
MRI signal abnormalities in adults with Brown-Vialetto-Van Laere syndrome
On 22/10/2021
Brown-Vialetto-Van Laere syndrome (BVVLS) is a very rare form of bulbspinal muscular atrophy which is treated with high doses of riboflavin. It results in motor…
The Institute of Myology jointly discovers a new form of X-linked distal myopathy
On 20/10/2021
An international collaboration that included researchers from the Institute of Myology has discovered a new form of distal myopathy, in 10 men: with adult onset…
Newborn screening for SMA becomes official in Belgium
On 20/10/2021
Several countries have already deployed pilot programs for newborn screening in the SMA, such as Germany, Australia, the United States, Taiwan … In Belgium, a…
ERN EURO-RND webinar, October 21st: Gisele Bonne (France), Carles Hernandez-Ferrer (Spain), Katja Lohmann (Germany)
On 19/10/2021
Rare Diseases’ therapies integration in diagnostic support tools through the Treatabolome platform Thursday October 21st, 2021 – 4pm (Paris Time) Gisele Bonne (Sorbonne University –…
The deterioration of respiratory and motor parameters is confirmed in non-walking patients with type III SMA
On 19/10/2021
SMA classically includes four types (I to IV) depending on the age of onset of the deficit and the maximum motor ability achieved by the…
WMS 2021: fairly encouraging results of losmapimod in facio-scapulo-humeral myopathy
On 18/10/2021
A selective inhibitor of p38 α and β MAP kinases, losmapimod has been investigated in a phase II trial called ReDUX4, randomized, double-blind, placebo-controlled, lasting…
Can physical exercise at home be useful in patients with myasthenia gravis?
On 18/10/2021
Myasthenia gravis is the result of an imbalance in the immune system, causing the production of autoantibodies that act against one of the building blocks…
A Swedish study finds that MG treatment leaves unsatisfactory symptomatic state for patients in almost half of cases
On 18/10/2021
In Sweden, 1,077 patients with myasthenia gravis from the Genes and Environment in Myasthenia Gravis study (GEMG) cohort completed a 106-item self-administered questionnaire including the…
Inflammatory myopathies: the molecular benefits of physical activity are revealed
On 16/10/2021
Appropriate physical activity is an integral part of the treatment of idiopathic myositis (or inflammatory myopathies), though the mechanisms of action being are not yet…
WMS2021 and SMA: between innovative therapy and biotherapy
On 15/10/2021
New clinical trial data in SMA were discussed during the latest edition of the World Muscle Society (WMS) congress from September 20-24, 2021. Out of…
ERN EURO-RND webinar, October 19th: Prof. Annemieke Aartsma-Rus (The Netherlands)
On 13/10/2021
Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting Tuesday October 19th, 2021 – 3-4pm (Paris Time) Prof. Annemieke Aartsma-Rus (Department of…
DMOP: a Dutch study specifies the evolutionary profile of the disease
On 11/10/2021
Oculopharyngeal muscular dystrophy (or OPDM) is a relatively rare myopathy transmitted on an autosomal dominant mode. It results in the gradual onset, as a rule…
Gastrointestinal manifestations of Pompe disease: confirmation of smooth muscle involvement
On 11/10/2021
Pompe disease is an inherited disease linked to the dysfunction of a lysosomal enzyme involved in the physiological glycogen breakdown. Transmitted on an autosomal recessive…
